We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Indian regulators have decided to abandon a proposed law that would have amended parts of India’s Drugs and Cosmetic Act of 1940, to pursue more extensive revisions to create a separate device regulation. Read More
Ireland’s Health Products Regulatory Authority is temporarily banning use of Biotest’s RightSign rapid tests for HIV, HCV and HBV distributed in the Irish market. Read More
Spot On Sciences marketed its products for diagnostic testing despite telling the FDA they were intended for research use only, according to a recent warning letter. Read More
Failure to validate equipment and computer software, and not establishing adequate procedures for implementing corrective and preventive actions, landed French devicemaker Eolane Vailhauques an FDA warning letter. Read More
Physicians and hospitals in the U.S. accepted $7.52 billion in payments and ownership and investment interests from the drug and medical device industry in 2015, according to data released by the Centers for Medicare & Medicaid Services. Read More